![]() |
市场调查报告书
商品编码
1392342
全球遗传检测市场研究报告 - 2023 年至 2030 年行业分析、规模、份额、成长、趋势和预测Global Hereditary Testing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030 |
预计到 2030 年,全球遗传检测市场的市场规模将从 2022 年的 76.3 亿美元达到近 156.6 亿美元,2023-2030 年研究期间CAGR为 9.4%。
遗传测试是为了识别特定基因组序列中特定基因的存在而进行的测试。基因可以透过定序直接鑑定或透过各种方法间接鑑定。遗传检测可以揭示可能导致疾病的基因变化(突变)。遗传检测在确定某些疾病的风险、筛检,有时甚至是医疗方面发挥着至关重要的作用。
不断增长的老年人口使人们更容易患慢性病,这增加了对预防性诊断,特别是遗传性检测的需求。此外,技术的不断进步为市场扩张提供了一些机会。为利基治疗领域开发客製化检测试剂盒有助于市场的快速成长。此外,各国政府越来越注重监管和提高人们对遗传检测的认识,导致这些检测在世界各地得到更快的采用。可能扩大遗传检测市场规模的另一个重要因素是对个人化药物的需求不断增长。然而,对基于遗传检测的诊断标准化和严格的产品审批程序的担忧预计将阻碍遗传检测市场的扩张。
研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外,这些工具也对全球遗传检测市场的各个细分市场进行了包容性评估。遗传检测产业的成长和趋势为本研究提供了整体方法。
本节涵盖区域前景,重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲遗传检测市场当前和未来的需求。此外,该报告重点关注所有主要地区各个应用领域的需求、估计和预测。
该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。遗传检测市场的主要参与者包括 Myriad Genetics Inc.、Invitae Corporation、Illumina, Inc.、Natera, Inc.、Laboratory Corporation of America Holdings、F. Hoffmann-La Roche Ltd、Quest Diagnostics Incorporated、CooperSurgical Inc.、Agilent Technologies Inc.、Thermo Fisher Scientific, Inc. 及其他本部分包含竞争格局的整体视图,其中包括各种策略发展,例如关键併购、未来产能、合作伙伴关係、财务概览、合作、新产品开发、新产品发布和其他开发。
如果您有任何客製化要求,请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。
The global demand for Hereditary Testing Market is presumed to reach the market size of nearly USD 15.66 BN by 2030 from USD 7.63 BN in 2022 with a CAGR of 9.4% under the study period 2023 - 2030.
Hereditary testing is a test performed to identify a particular gene's presence within a particular genome sequence. The genes can be identified directly through sequencing or indirectly via various methods. Hereditary testing can reveal changes (mutations) in the genes that may cause illness or disease. Hereditary testing plays a vital role in determining the risk of developing certain diseases, screening, and sometimes medical treatment.
The growing geriatric population makes people more susceptible to chronic diseases, which increases the demand for preventive diagnostics, particularly hereditary testing. Moreover, the increasing technological advancements have opened several opportunities for market expansion. Developing customized testing kits for niche therapeutic areas is assisting the market's rapid growth. Furthermore, governments' increasing focus on regulating and creating awareness regarding hereditary tests has resulted in faster adoption of these tests around the world. Another important factor that could increase the size of the hereditary testing market is the growing need for personalized medication. However, worries over the standardization of hereditary testing-based diagnoses and tight product approval procedures are projected to hamper the hereditary testing market's expansion.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of hereditary testing. The growth and trends of hereditary testing industry provide a holistic approach to this study.
This section of the hereditary testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Hereditary Testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the hereditary testing market include Myriad Genetics Inc., Invitae Corporation, Illumina, Inc., Natera, Inc., Laboratory Corporation of America Holdings, F. Hoffmann-La Roche Ltd, Quest Diagnostics Incorporated, CooperSurgical Inc., Agilent Technologies Inc., Thermo Fisher Scientific, Inc. and Others This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.